Analysen des Paul-Ehrlich Instituts zur Sicherheit der COVID-19-Impfstoffe
Original
Introduced
13 January 2023
Last action
13 January 2023 · Schriftliche Frage/Schriftliche Antwort
Status
Beantwortet
Sponsors
—
Subjects
Discovery layer
Source updated
17 June 2024
Summary
Originaltext der Frage(n):<br /> <br /> Hat die Bundesregierung Kenntnis über die Disproportionalitätsanalysen in den ADR-Datenbanken des Paul-Ehrlich-Instituts zu allen COVID-19-Impfstoffen, und wenn ja, bitte die Analysen angeben?
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
13 January 2023
Schriftliche Frage/Schriftliche Antwort
Analysen des Paul-Ehrlich Instituts zur Sicherheit der COVID-19-Impfstoffe
Source: BT
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://dip.bundestag.de/vorgang/analysen-des-paul-ehrlich-instituts-zur-sicherheit-der-covid-19-impfstoffe/295477
- Open data entity: https://search.dip.bundestag.de/api/v1/vorgang/295477
- germany · 295477 · source updated 17 June 2024